RecruitingNCT07033169

A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis

A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis of Commonly Encountered Dermatologic Diseases


Sponsor

Wake Forest University Health Sciences

Enrollment

400 participants

Start Date

Sep 15, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Consented patients will have three images taken of their dermatologic conditions within the Belle.ai software. These images will be uploaded and saved within the Belle software system where a single AI-generated differential list will be generated based on the three photos. All photos uploaded will be de-identified. The software will not have any unique identifiers of participants saved in the system. The photos will be named based on participant enrollment numbers or unique code numbers and no unique identifiers will be attached to the photos. There will be no data collection form necessary for this study


Eligibility

Min Age: 10 Years

Inclusion Criteria3

  • Patient must present to an Advocate Health dermatology clinic
  • Patient must have the ability and willingness to provide informed consent and comply with study procedures and visits
  • Participant dermatologists must have access to the required technology (e.g., smartphone with internet access) and be capable of using it for the required image capture

Exclusion Criteria2

  • Patients who are unable to comply with study procedures due to physical or mental health limitations (as assessed by study coordinator)
  • Pediatric, adolescent, and teen patients who present with dermatological conditions on their genitalia will not be included in the study (in support of patient privacy concerns).

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Wake Forest University Health Sciences Department of Dermatology

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07033169


Related Trials